CVS Health stock trades at EUR 79.72 with a 23.36 price-to-earnings ratio

Published on 10/13/2026 at 15:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Market value is USD 113.0 billion on October 13, 2026. CVS Health stock costs EUR 79.72 on October 13, 2026, up 2.44 percent versus the Xetra close.

Valuation and price position

CVS Health traded on NYSE with a 23.36 price-to-earnings ratio on October 13, 2026.
Market value stood at USD 113.0 billion on October 13, 2026.
CVS Health stock costs EUR 79.72 at Lang & Schwarz on October 13, 2026 at 3:32 p.m. CEST, 2.44 percent above the Xetra close of October 12, 2026.
The EUR 96.90 52-week high stood 17.73 percent above the Lang & Schwarz price.

Aquarellbild eines amerikanischen Gesundheitszentrums mit Bäumen und Parkplatz in Pastellfarben — CVS Health Corp. Aquarell-Illustration zeigt amerikanisches Gesundheitszentrum im sonnigen Vorort, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health stock's valuation showed a 23.36 price-to-earnings ratio and a 3.00 percent dividend yield on October 13, 2026. At Lang & Schwarz, the stock was trading at EUR 79.72 on October 13, 2026 at 3:32 p.m. CEST, plus 2.44 percent versus the Xetra close of October 12, 2026 at EUR 77.82.

Valuation sets the frame

The market value was USD 113.0 billion on October 13, 2026, based on the latest primary-market quote. That places the company among the larger listed health care businesses, while the 23.36 ratio provides a clear valuation marker for the stock.

MarketBeat identifies CVS Health as NYSE: CVS and describes the business as an integrated health care company spanning pharmacy, insurance and health services.

Price sits below yearly high

The EUR 79.72 quote stood within a 52-week range of EUR 59.71 to EUR 96.90 on October 13, 2026. The price was 17.73 percent below the upper end of that range, calculated from the Lang & Schwarz quote and the same-currency 52-week high.

The session quote was EUR 1.90 above the Xetra close of October 12, 2026. That difference equals a 2.44 percent gain, calculated from EUR 79.72 divided by EUR 77.82 minus one.

Valuation and peer prices

The 3.00 percent dividend yield adds an income measure to the valuation picture on October 13, 2026. Trading volume for CVS Health was 212,824 shares, compared with an average volume of 8,061,445 shares in the same quote window.

Comparison with peers

CVS Health Corp. (NYSE, USD): plus 2.44 percent, price-to-earnings ratio 23.36, market capitalization USD 113.0 billion.

Cigna Corporation (NYSE, USD): plus 0.59 percent, price-to-earnings ratio 11.85, market capitalization USD 75.3 billion.

UnitedHealth Group Incorporated (NYSE, USD): plus 2.45 percent, price-to-earnings ratio 25.07, market capitalization USD 352.2 billion.

Lang & Schwarz price and range

For German-market readers, the key reference remains the euro quote: CVS Health was trading at EUR 79.72 at Lang & Schwarz on October 13, 2026 at 3:32 p.m. CEST, 2.44 percent above the Xetra close of October 12, 2026 at EUR 77.82. The 52-week high of EUR 96.90 was 17.73 percent higher than the current euro price.

The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.